Phibro Animal Health Corporation Reports Third Quarter

Go back to Phibro Animal Health Corporation Reports Third Quarter

Cantor Fitzgerald Raises Price Target on Phibro Animal Health (PAHC) Based on Growth Prospects

May 13, 2015 12:14 PM EDT

Cantor Fitzgerald reiterates its Buy rating on Phibro Animal Health Corp. (Nasdaq: PAHC), and raised the price target to $42.00 (from $36.00), based on growth prospects.

Notably, on Tuesday night, Phibro Animal management updated its FY15 guidance, which is now revenue of $749 - $754M in revenue (from $739 - $759M), adjusted EBITDA of $109 - $110M in adjusted EBITDA (from $103 -... More

Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40

May 12, 2015 11:34 AM EDT

Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from $35.00), following F3Q15 beat. PAHC reported an adjusted diluted EPS of $0.41 ($0.05 higher than consensus and $0.07 better than Guggenheim estimate). PAHC management raised the '15 EPS guidance from... More

Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield

May 11, 2015 4:52 PM EDT

Phibro Animal Health (NASDAQ: PAHC) declared a quarterly dividend of $0.10 per share, or $0.4 annualized.

The dividend will be payable on June 24, 2015, to stockholders of record on June 3, 2015, with an ex-dividend date of June 1, 2015.

The annual yield on the dividend is 1.2... More

Phibro Animal Health (PAHC) Tops Q3 EPS by 5c; Guides FY15 EPS Above Expectations

May 11, 2015 4:51 PM EDT

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $187 million versus the consensus estimate of $187.8 million.

Phibro Animal Health sees FY2015 EPS of $1.65-$1.67, versus the consensus of $1.62. Phibro Animal... More